Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Study the Efficacy, Safety and Pharmacokinetics of COVID-globulin, in Addition to Standard Therapy for the Treatment of Patients With a Moderate COVID-19 Form

NCT04842435 is registered in ClinicalTrials.gov with Microgen as lead sponsor.

NCT NCT04842435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04842435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Study the Efficacy, Safety and Pharmacokinetics of COVID-globulin, in Addition to Standard Therapy for the Treatment of Patients With a Moderate COVID-19 Form
Lead sponsor
Microgen
Phase
Phase 2/3
Overall status
Unknown status
Start date
April 12, 2021
Completion date
October 5, 2021
Enrollment
376 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19